PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or InhibitionYilun Wu, Wenyi Gu|Frontiers in Immunology|2019Cited by 411
<scp>PI</scp>3K/Akt/<scp>mTOR</scp> pathway dual inhibitor <scp>BEZ</scp>235 suppresses the stemness of colon cancer stem cellsJiezhong Chen, Wenyi Gu|Clinical and Experimental Pharmacology and Physiology|2015Cited by 98
Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cellsMingshui Chen, Wenyi Gu|BMC Cancer|2019Cited by 54
Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosisWenyi Gu, Michael J. Monteiro|International Journal of Nanomedicine|2016Cited by 52
Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh populationXiaobin Cui, Feng Li, Xuelian Pang et al.|Gene|2013Cited by 43